Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rucaparib in Nonmetastatic Hormone-Sensitive Prostate Cancer (ROAR)
NCT03533946Phase 2Terminated
- Sponsor
- University of Utah
- Start
- May 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rucaparib in prostate cancer (PCa), sponsored by University of Utah. Started May 2019; status: terminated.
02
Drugs
rucaparib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03533946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03533946.